Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Personalizing Precision Oncology Clinical Trials in Latin America: An Expert Panel on Challenges and Opportunities.

Arai RJ, Guindalini RSC, Llera AS, O'Connor JM, Muller B, Lema M, Freitas HC, Soria T, Delgado L, Landaverde D, Montenegro P, Riechelmann RP.

Oncologist. 2019 Mar 25. pii: theoncologist.2018-0318. doi: 10.1634/theoncologist.2018-0318. [Epub ahead of print]

PMID:
30910864
2.

Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil.

Guindalini RSC, Cormedi MCV, Maistro S, Pasini FS, Branas PCAA, Dos Santos L, de Lima Pereira GF, de Bock GH, Saccaro DM, Katayama MLH, Faraj SF, Safatle-Ribeiro A, Ribeiro Junior U, Diz MDPE, de Gouvêa ACRC, Chammas R, Folgueira MAAK.

Gastric Cancer. 2019 Mar 20. doi: 10.1007/s10120-019-00945-9. [Epub ahead of print]

PMID:
30895400
3.

From colorectal cancer pattern to the characterization of individuals at risk: Picture for genetic research in Latin America.

Vaccaro CA, López-Kostner F, Adriana DV, Palmero EI, Rossi BM, Antelo M, Solano A, Carraro DM, Forones NM, Bohorquez M, Lino-Silva LS, Buleje J, Spirandelli F, Abe-Sandes K, Nascimento I, Sullcahuaman Y, Sarroca C, Gonzalez ML, Herrando AI, Alvarez K, Neffa F, Galvão HC, Esperon P, Golubicki M, Cisterna D, Cardoso FC, Torrezan GT, Junior SA, Pimenta CAM, da Cruz Formiga MN, Santos E, Sá CU, Oliveira EP, Fujita R, Spirandelli E, Jimenez G, Guindalini RSC, de Azevedo RGMV, Bueno LSM, Dos Santos Nogueira ST, Loarte MT, Padron J, Del Carmen Castro-Mujica M, Del Monte JS, Caballero C, Peña CMM, Pinto J, Barletta-Carrillo C, Melva GA, Piñero T, Beltran PM, Ashton-Prolla P, Rodriguez Y, Quispe R, Rossi NT, Martin C, Chialina S, Kalfayan PG, Bazo-Alvarez JC, Cañete AR, Dominguez-Barrera C, Nuñez L, Da Silva SD, Balavarca Y, Wernhoff P, Plazzer JP, Møller P, Hovig E, Dominguez-Valentin M; in collaboration with GETH.

Int J Cancer. 2019 Jul 15;145(2):318-326. doi: 10.1002/ijc.31920. Epub 2018 Dec 5. Review.

PMID:
30303536
4.

Criteria for eligibility to cisplatin in the curative treatment of head and neck cancer: Consensus opinion from a panel of experts.

de Castro G Jr, Alves GV, Castro AF, Chaves ALF, De Marchi P, de Oliveira TB, Dias FL, Guindalini RSC, Nicolau UR, Soares A, Mora PAR.

Crit Rev Oncol Hematol. 2018 Nov;131:30-34. doi: 10.1016/j.critrevonc.2018.08.009. Epub 2018 Aug 27. Review.

PMID:
30293703
5.

Survival and prognosis of young adults with gastric cancer.

Cormedi MCV, Katayama MLH, Guindalini RSC, Faraj SF, Folgueira MAAK.

Clinics (Sao Paulo). 2018 Sep 21;73(suppl 1):e651s. doi: 10.6061/clinics/2018/e651s.

6.

Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers.

Guindalini RSC, Zheng Y, Abe H, Whitaker K, Yoshimatsu TF, Walsh T, Schacht D, Kulkarni K, Sheth D, Verp MS, Bradbury AR, Churpek J, Obeid E, Mueller J, Khramtsova G, Liu F, Raoul A, Cao H, Romero IL, Hong S, Livingston R, Jaskowiak N, Wang X, Debiasi M, Pritchard CC, King MC, Karczmar G, Newstead GM, Huo D, Olopade OI.

Clin Cancer Res. 2019 Mar 15;25(6):1786-1794. doi: 10.1158/1078-0432.CCR-18-0200. Epub 2018 Aug 28.

PMID:
30154229
7.

The germline mutational landscape of BRCA1 and BRCA2 in Brazil.

Palmero EI, Carraro DM, Alemar B, Moreira MAM, Ribeiro-Dos-Santos Â, Abe-Sandes K, Galvão HCR, Reis RM, de Pádua Souza C, Campacci N, Achatz MI, Brianese RC, da Cruz Formiga MN, Makdissi FB, Vargas FR, Evangelista Dos Santos AC, Seuanez HN, Lobo de Souza KR, Netto CBO, Santos-Silva P, da Silva GS, Burbano RMR, Santos S, Assumpção PP, Bernardes IMM, Machado-Lopes TMB, Bomfim TF, Toralles MBP, Nascimento I, Garicochea B, Simon SD, Noronha S, de Lima FT, Chami AM, Bittar CM, Bines J, Artigalas O, Esteves-Diz MDP, Lajus TBP, Gifoni ACLVC, Guindalini RSC, Cintra TS, Schwartz IVD, Bernardi P, Miguel D, Nogueira STDS, Herzog J, Weitzel JN, Ashton-Prolla P.

Sci Rep. 2018 Jun 15;8(1):9188. doi: 10.1038/s41598-018-27315-2.

8.

Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis.

Debiasi M, Polanczyk CA, Ziegelmann P, Barrios C, Cao H, Dignam JJ, Goss P, Bychkovsky B, Finkelstein DM, Guindalini RS, Filho P, Albuquerque C, Reinert T, de Azambuja E, Olopade O.

Front Oncol. 2018 May 22;8:156. doi: 10.3389/fonc.2018.00156. eCollection 2018. Review.

9.

Validation of questionnaire on the Spiritual Needs Assessment for Patients (SNAP) questionnaire in Brazilian Portuguese.

de Araujo Toloi D, Uema D, Matsushita F, da Silva Andrade PA, Branco TP, de Carvalho Chino FT, Guerra RB, Pfiffer TE, Chiba T, Guindalini RS, Sulmasy DP, Riechelmann RP.

Ecancermedicalscience. 2016 Nov 22;10:694. doi: 10.3332/ecancer.2016.694. eCollection 2016.

10.

Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect.

Guindalini RS, Song A, Fackenthal JD, Olopade OI, Huo D.

Cancer. 2016 Jun 15;122(12):1913-20. doi: 10.1002/cncr.29972. Epub 2016 Mar 15.

11.

Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome.

Guindalini RS, Win AK, Gulden C, Lindor NM, Newcomb PA, Haile RW, Raymond V, Stoffel E, Hall M, Llor X, Ukaegbu CI, Solomon I, Weitzel J, Kalady M, Blanco A, Terdiman J, Shuttlesworth GA, Lynch PM, Hampel H, Lynch HT, Jenkins MA, Olopade OI, Kupfer SS.

Gastroenterology. 2015 Nov;149(6):1446-53. doi: 10.1053/j.gastro.2015.07.052. Epub 2015 Aug 3.

12.

Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population.

Felix GE, Abe-Sandes C, Machado-Lopes TM, Bomfim TF, Guindalini RS, Santos VC, Meyer L, Oliveira PC, Cláudio Neiva J, Meyer R, Romeo M, Betânia Toralles M, Nascimento I, Abe-Sandes K.

Hum Genome Var. 2014 Oct 16;1:14012. doi: 10.1038/hgv.2014.12. eCollection 2014.

13.

Multiagent chemotherapy for metastatic adenocarcinoma of the seminal vesicle.

Guindalini RS, Mak MP, Takahashi TK, Testa L, Dzik C.

Anticancer Drugs. 2014 Jan;25(1):115-9. doi: 10.1097/CAD.0000000000000030.

PMID:
24113594
14.

Should extragonadal germ cell tumors be included in studies of families with testicular germ cell tumors?

Guindalini RS, de Oliveira EP, Silvino MC, Hoff PM, Garicochea B.

Hered Cancer Clin Pract. 2013 Mar 4;11(1):1. doi: 10.1186/1897-4287-11-1.

15.

Resistance to trastuzumab in HER2-positive mucinous invasive ductal breast carcinoma.

Baretta Z, Guindalini RS, Khramtsova G, Olopade OI.

Clin Breast Cancer. 2013 Apr;13(2):156-8. doi: 10.1016/j.clbc.2012.11.007. Epub 2012 Dec 29. No abstract available.

16.

Supportive care in head and neck oncology.

de Castro G Jr, Guindalini RS.

Curr Opin Oncol. 2010 May;22(3):221-5. doi: 10.1097/CCO.0b013e32833818ff. Review.

PMID:
20186057
17.

Veress needle insertion in the left hypochondrium in creation of the pneumoperitoneum.

Azevedo OC, Azevedo JL, Sorbello AA, Miguel GP, Guindalini RS, Godoy AC.

Acta Cir Bras. 2006 Sep-Oct;21(5):296-303.

18.

Evaluation of the positioning of the tip of the Veress needle during creation of closed pneumoperitoneum in pigs.

Azevedo JL, Guindalini RS, Sorbello AA, Silva CE, Azevedo OC, Aguiar Gda S, Menezes FJ, Delorenzo A, Pasqualin RC, Kozu FO.

Acta Cir Bras. 2006 Jan-Feb;21(1):26-30. Epub 2006 Feb 13.

Supplemental Content

Loading ...
Support Center